title: Amping up effort: effects of d-amphetamine on human effort-based decision-making.
abstract: Animal studies suggest the neurotransmitter dopamine (DA) plays an important role in decision-making. In rats, DA depletion decreases tolerance for effort and probability costs, while drugs enhancing DA increase tolerance for these costs. However, data regarding the effect of DA manipulations on effort and probability costs in humans remain scarce. The current study examined acute effects of d-amphetamine, an indirect DA agonist, on willingness of healthy human volunteers to exert effort for monetary rewards at varying levels of reward value and reward probability. Based on preclinical research, we predicted amphetamine would increase exertion of effort, particularly when reward probability was low. Over three sessions, 17 healthy normal adults received placebo, d-amphetamine 10 mg, and 20 mg under counterbalanced double-blind conditions and completed the Effort Expenditure for Rewards Task. Consistent with predictions, amphetamine enhanced willingness to exert effort, particularly when reward probability was lower. Amphetamine did not alter effects of reward magnitude on willingness to exert effort. Amphetamine sped task performance, but its psychomotor effects were not strongly related to its effects on decision-making. This is the first demonstration in humans that dopaminergic manipulations alter willingness to exert effort for rewards. These findings help elucidate neurochemical substrates of choice, with implications for neuropsychiatric diseases characterized by dopaminergic dysfunction and motivational deficits.
authors.affiliation: Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois 60637, USA.
authors.forename: Margaret C
authors.initials: MC
authors.lastname: Wardle
authors.forename: Michael T
authors.initials: MT
authors.lastname: Treadway
authors.forename: Leah M
authors.initials: LM
authors.lastname: Mayo
authors.forename: David H
authors.initials: DH
authors.lastname: Zald
authors.forename: Harriet
authors.initials: H
authors.lastname: de Wit
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D003657:Decision Making / Q000187:drug effects*; D003913:Dextroamphetamine / Q000008:administration & dosage*; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008960:Models, Psychological; D009042:Motivation / Q000187:drug effects*; D009483:Neuropsychological Tests; D011336:Probability; D011597:Psychomotor Performance / Q000187:drug effects; D012201:Reward; D055815:Young Adult
chemical_list: D018765:Dopamine Uptake Inhibitors; D003913:Dextroamphetamine
references.citation: Biometrics. 1986 Mar;42(1):121-30
references.pmid: 3719049
references.citation: Neuropsychopharmacology. 2011 Jan;36(1):114-32
references.pmid: 20881944
references.citation: Psychopharmacology (Berl). 2005 May;179(3):587-96
references.pmid: 15864561
references.citation: Nat Neurosci. 2006 Sep;9(9):1161-8
references.pmid: 16921368
references.citation: Front Behav Neurosci. 2009 Sep 07;3:13
references.pmid: 19826615
references.citation: Behav Neurosci. 2009 Apr;123(2):242-51
references.pmid: 19331447
references.citation: Nature. 2011 Jun 29;475(7356):377-80
references.pmid: 21716290
references.citation: J Neurosci. 2008 May 28;28(22):5623-30
references.pmid: 18509023
references.citation: J Neurosci. 2010 Sep 8;30(36):12020-7
references.pmid: 20826665
references.citation: Neuropsychopharmacology. 2011 Nov;36(12):2469-76
references.pmid: 21775977
references.citation: Pharmacol Biochem Behav. 2002 Nov;73(4):729-41
references.pmid: 12213517
references.citation: Psychopharmacology (Berl). 2012 Mar;220(1):143-53
references.pmid: 21947316
references.citation: Psychopharmacology (Berl). 2007 Apr;191(3):483-95
references.pmid: 17119929
references.citation: Neurosci Biobehav Rev. 2011 Jan;35(3):537-55
references.pmid: 20603146
references.citation: J Neurophysiol. 2010 Jul;104(1):313-21
references.pmid: 20463204
references.citation: Psychopharmacology (Berl). 2007 Apr;191(3):461-82
references.pmid: 17225164
references.citation: Neuron. 2009 May 28;62(4):593-602
references.pmid: 19477159
references.citation: Neuroscience. 2001;105(4):863-70
references.pmid: 11530224
references.citation: Pharmacol Biochem Behav. 1994 Sep;49(1):25-31
references.pmid: 7816884
references.citation: J Neurosci. 2010 Oct 20;30(42):14080-90
references.pmid: 20962229
references.citation: Psychopharmacology (Berl). 2010 Aug;211(2):209-21
references.pmid: 20495787
references.citation: Behav Brain Res. 2002 Dec 2;137(1-2):179-87
references.pmid: 12445723
references.citation: Psychopharmacology (Berl). 2009 Aug;205(2):189-201
references.pmid: 19365622
references.citation: PLoS One. 2009 Aug 12;4(8):e6598
references.pmid: 19672310
references.citation: Neuron. 2009 Sep 24;63(6):733-45
references.pmid: 19778504
references.citation: Behav Brain Res. 1996 Jan;74(1-2):189-97
references.pmid: 8851929
references.citation: Neural Netw. 2006 Oct;19(8):1302-14
references.pmid: 16949252
references.citation: J Neurosci. 2010 Jan 27;30(4):1426-34
references.pmid: 20107069
references.citation: Neuropsychopharmacology. 2002 Nov;27(5):813-25
references.pmid: 12431855
references.citation: Ann N Y Acad Sci. 1988;537:228-34
references.pmid: 3059926
references.citation: Cereb Cortex. 2009 Oct;19(10):2240-7
references.pmid: 19131436
references.citation: Am J Epidemiol. 1986 Oct;124(4):678-83
references.pmid: 3752061
references.citation: Mol Psychiatry. 2004 Jun;9(6):557-69
references.pmid: 15098002
references.citation: Psychopharmacology (Berl). 1991;104(4):515-21
references.pmid: 1780422
references.citation: Psychopharmacology (Berl). 2000 May;150(1):90-101
references.pmid: 10867981
references.citation: Neuropsychopharmacology. 2009 Dec;34(13):2758-66
references.pmid: 19741594
references.citation: Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17199-204
references.pmid: 19805082
references.citation: Neuropsychopharmacology. 2008 Jul;33(8):1966-79
references.pmid: 17805307
references.citation: Neuropsychopharmacology. 2009 Feb;34(3):681-97
references.pmid: 18668030